NovoCare Pharmacy Review
Best for: branded Wegovy at the lowest manufacturer-direct self-pay price
Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide). Manufacturer-owned channel: Wegovy 0.25 mg / 0.5 mg starter doses at $199/month through 6/30/2026; full-dose Wegovy at $349/month standard self-pay; Wegovy HD at $399/month. Ships nationwide. Distinct from telehealth platforms that route Wegovy through NovoCare — this is the manufacturer pharmacy itself.
High confidence · Last verified 2026-05-09 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
NovoCare Pharmacy is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
NovoCare Pharmacy prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Wegovy 0.25 mg / 0.5 mg (starter, intro pricing through 6/30/2026) | brand | $199 |
| Wegovy 1.0 / 1.7 / 2.4 mg (standard self-pay) | brand | $349 |
| Wegovy HD (high-dose) | brand | $399 |
✓ Pros
- •First-party manufacturer pharmacy — the most authoritative branded Wegovy channel possible
- •$199/month intro pricing for Wegovy 0.25 mg and 0.5 mg starter doses (through 6/30/2026) is the lowest brand-name self-pay price for the FDA-approved Wegovy product
- •$349/month standard self-pay for full-dose Wegovy is well below the ~$1,300/month list price at retail pharmacies
- •Ships to all 50 states; no telehealth-platform middleman fees
- •Cold-chain logistics handled by Novo Nordisk directly — no risk of mishandling between manufacturer and patient
- •Insurance-billing path also available via the standard NovoCare savings program
✗ Cons
- •Wegovy only — no semaglutide for type 2 diabetes (Ozempic), no compounded GLP-1, no tirzepatide
- •Requires an existing valid Wegovy prescription — NovoCare Pharmacy does not employ prescribing clinicians or operate a telehealth intake. You need a separate visit (PCP, endocrinologist, or another telehealth provider) to get the script first
- •$199 intro pricing is dose-restricted (0.25 mg / 0.5 mg only) and time-limited (through 6/30/2026) — most patients on the maintenance 1.7 / 2.4 mg dose pay $349/month
- •No clinical support included with the pharmacy fulfillment — your prescribing clinician handles titration and side-effect monitoring
- •Manufacturer-set pricing can change at any time
Ready to start with NovoCare Pharmacy?
Starting at $199/month. See current pricing and start your free consultation.
Sources & methodology
Our NovoCare Pharmacy review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to NovoCare Pharmacy
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with NovoCare Pharmacy?
Starting at $199/month. See current pricing and start your free consultation.